ACC, Boehringer Ingelheim And Eli Lilly And Company To Advance HF Treatment Through SGLT2 Inhibitor Education

WASHINGTON, Oct. 5 (TNSres) -- The American College of Cardiology issued the following news release on Oct. 4, 2022:

* * *

Initiative will educate clinicians, patients on the guideline-directed uses of SGLT2 inhibitors to improve HF outcomes

* * *

The American College of Cardiology, in collaboration with Boehringer Ingelheim and Eli Lilly and Company (Lilly), is launching an initiative to educate cardiologists who are familiar with the drug evi . . .

To gain access to full content fill out the form below.

Information Request Form

I'd like more information
Sign me up for a free trial

Name:
Newspaper/Company:
Email:
Phone:
State:
Keywords or Areas of Interest:

Select Product(s) you are interested in:
Daily Federal Tipoffs for your City/State
Congressional Vote Chart
Federal Contract Awards
Federal Patent Awards
News Releases from Federal Agencies
News Releases from States
News Releases from Counties
News Releases from Cities
Golf Handicap site (FairwayFiles.com)

Filling out this form will generate a contact, by phone or e-mail, from a TNS editor. No automated information is provided. How would you like to be contacted: Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Nicole Napoli, 202/375-6523, nnapoli@acc.org